Konstantin Mayer1, Martina B Schaefer, Werner Seeger. 1. Lung Center, Department of Internal Medicine II, University of Giessen, Giessen, Germany. Konstantin.Mayer@innere.med.uni-giessen.de
Abstract
PURPOSE OF REVIEW: The aim of this paper is to describe recent relevant literature concerning the role of n-3 lipids derived from fish oil in clinical nutrition in an intensive care setting. RECENT FINDINGS: N-3 fatty acids compete with arachidonic acid for metabolism to lipid mediators and exert profound effects on second mediator generation and dependent cellular functions. In experimental models, dietary and parenteral use of fish oil was shown to protect the gut by increasing its perfusion. In contrast, use of immunonutrition including fish oil in critical ill patients or patients with severe sepsis may exert an excess mortality. Using parenteral fish oil in surgical patients promising data became available. In septic patients, immunologic effects of fish oil-based lipid emulsions have been found and intravenous supplementation with fish oil may have a beneficial impact on mortality and length of stay. For both patient groups, however, prospective data from randomized trials are lacking. SUMMARY: N-3 lipids exhibit strong immunologic properties. They offer the possibility to counterbalance the negative effects of conventional n-6 fatty acids. Recent studies exhibit positive effects of intravenous use of fish oil on immunologic functions and clinical parameters in surgical and septic patients.
PURPOSE OF REVIEW: The aim of this paper is to describe recent relevant literature concerning the role of n-3 lipids derived from fish oil in clinical nutrition in an intensive care setting. RECENT FINDINGS:N-3 fatty acids compete with arachidonic acid for metabolism to lipid mediators and exert profound effects on second mediator generation and dependent cellular functions. In experimental models, dietary and parenteral use of fish oil was shown to protect the gut by increasing its perfusion. In contrast, use of immunonutrition including fish oil in critical ill patients or patients with severe sepsis may exert an excess mortality. Using parenteral fish oil in surgical patients promising data became available. In septic patients, immunologic effects of fish oil-based lipid emulsions have been found and intravenous supplementation with fish oil may have a beneficial impact on mortality and length of stay. For both patient groups, however, prospective data from randomized trials are lacking. SUMMARY: N-3 lipids exhibit strong immunologic properties. They offer the possibility to counterbalance the negative effects of conventional n-6 fatty acids. Recent studies exhibit positive effects of intravenous use of fish oil on immunologic functions and clinical parameters in surgical and septic patients.
Authors: J D Figueroa; K Cordero; M Serrano-Illan; A Almeyda; K Baldeosingh; F G Almaguel; M De Leon Journal: Neuroscience Date: 2013-09-14 Impact factor: 3.590
Authors: Sigrun Friesecke; Christian Lotze; Jenny Köhler; Annegret Heinrich; Stephan B Felix; Peter Abel Journal: Intensive Care Med Date: 2008-03-21 Impact factor: 17.440
Authors: Konstantin Mayer; Almuth Kiessling; Juliane Ott; Martina Barbara Schaefer; Matthias Hecker; Ingrid Henneke; Richard Schulz; Andreas Günther; Jingdong Wang; Lijun Wu; Joachim Roth; Werner Seeger; Jing X Kang Journal: Am J Respir Crit Care Med Date: 2009-01-08 Impact factor: 21.405
Authors: Joerg Glatzle; Stefan Beckert; Michael S Kasparek; Mario H Mueller; Petra Mayer; Tobias Meile; Alfred Konigsrainer; Wolfgang Steurer Journal: Langenbecks Arch Surg Date: 2007-03-23 Impact factor: 3.445